These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 22291397)

  • 41. Bushen‑Yizhi formula ameliorates cognition deficits and attenuates oxidative stress‑related neuronal apoptosis in scopolamine‑induced senescence in mice.
    Hou XQ; Wu DW; Zhang CX; Yan R; Yang C; Rong CP; Zhang L; Chang X; Su RY; Zhang SJ; He WQ; Qu Z; Li S; Su ZR; Chen YB; Wang Q; Fang SH
    Int J Mol Med; 2014 Aug; 34(2):429-39. PubMed ID: 24919922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies.
    Morain P; Lestage P; De Nanteuil G; Jochemsen R; Robin JL; Guez D; Boyer PA
    CNS Drug Rev; 2002; 8(1):31-52. PubMed ID: 12070525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Further evidence for a dissociation between different forms of mnemonic expressions in a mouse model of age-related cognitive decline: effects of tacrine and S 17092, a novel prolyl endopeptidase inhibitor.
    Marighetto A; Touzani K; Etchamendy N; Torrea CC; De Nanteuil G; Guez D; Jaffard R; Morain P
    Learn Mem; 2000; 7(3):159-69. PubMed ID: 10837505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease.
    Simard M; van Reekum R
    Drugs Aging; 1999 Mar; 14(3):197-230. PubMed ID: 10220105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test.
    Ballard TM; Hunter AJ; Bennett GW
    Psychopharmacology (Berl); 1996 Oct; 127(3):265-75. PubMed ID: 8912405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissociations in the expression of the sedative effects of triazolam.
    Weingartner HJ; Sirocco K; Rawlings R; Joyce E; Hommer D
    Psychopharmacology (Berl); 1995 May; 119(1):27-33. PubMed ID: 7675946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
    Coiro V; Volpi R; Capretti L; Caffarri G; Colla R; Chiodera P
    J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nefiracetam ameliorates associative learning impairment in the scopolamine-injected older rabbit.
    Pak J; Green J; Heifets B; Pak M; Woodruff-Pak D
    Med Sci Monit; 2002 Apr; 8(4):BR105-12. PubMed ID: 11951055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP; Owings J; Hayford JT; Blizzard RM
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers.
    Molchan SE; Mellow AM; Hill JL; Weingartner H; Martinez R; Vitiello B; Sunderland T
    J Psychopharmacol; 1992 Jan; 6(4):489-500. PubMed ID: 22291397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging.
    Araujo JA; Studzinski CM; Milgram NW
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):411-22. PubMed ID: 15795050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of neuropeptides on cognitive function.
    Bennett GW; Ballard TM; Watson CD; Fone KC
    Exp Gerontol; 1997; 32(4-5):451-69. PubMed ID: 9315449
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.